National Cancer Institute; Amended Notice of Meeting, 72495 [E8-28208]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 230 / Friday, November 28, 2008 / Notices
Building, Room 5b01, Bethesda, MD 20892,
(301) 435–6911, hopmannm@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: November 20, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–28206 Filed 11–26–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel,
February 11, 2009, 8 a.m. to February
13, 2009, 5 p.m., Hilton Washington/
Rockville, 1750 Rockville Pike,
Rockville, MD 20852 which was
published in the Federal Register on
October 15, 2008, 73 FR 61143.
This notice is amended to change the
date & time from February 11, 2009, 8
a.m. to February 13, 2009, 5 p.m. to
February 11, 7 a.m. to February 12,
2009, 5 p.m. The meeting is closed to
the public.
Dated: November 20, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–28208 Filed 11–26–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on PROD1PC66 with NOTICES
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2); notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections 552b(c)
(4) and 552b(c) (6), Title 5 U.S.C., as
amended. The grant applications and
the discussions could disclose
VerDate Aug<31>2005
17:16 Nov 26, 2008
Jkt 217001
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, P01
Mullins, Immunological and Virological
Events in Early HIV.
Date: December 17, 2008.
Time: 9 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health, 6116
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Olivia Preble Bartlett,
PhD., Chief, Research Programs Review
Branch, Division of Extramural Activities,
National Cancer Institute, 8th Floor, Room
8121, 6116 Executive Boulevard, Rockville,
MD 20892–7405, 301/594–2501,
op2t@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Cellular &
Tissue Biology P01.
Date: February 5–6, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: Marriott Bethesda North Hotel &
Conference Center, 5701 Marinelli Road,
Rockville, MD 20852.
Contact Person: Shakeel Ahmad, PhD.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Boulevard, Room 8139,
Bethesda, MD 20892–8328, (301) 594–0114,
ahmads@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Molecular
Oncology P01.
Date: February 5–6, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Bethesda North Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Michael B. Small, Ph.D.,
Scientific Review Officer, Research Program
Review Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Blvd., Room 8127, Bethesda, MD
20892–8328, 301–402–0996,
smallm@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel SPORE in
Leukemia, Lymphoma, Sarcoma, HN, GI, and
Lung Cancers.
Date: February 11–12, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Shamala K. Srinivas, PhD.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Boulevard, Room 8123, Bethesda,
MD 20892, 301–594–1224, ss537t@nih.gov.
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
72495
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: November 20, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–28209 Filed 11–26–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
NIH Support for Conference and Scientific
Meetings.
Date: December 9, 2008.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: David A. Wilson, PhD,
Scientific Review Administrator, Review
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7204, Bethesda, MD 20892–7924, 301–435–
0299, wilsonda2@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Research Demonstration and Dissemination
Projects.
Date: December 11, 2008.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
E:\FR\FM\28NON1.SGM
28NON1
]]>Agencies
[Federal Register Volume 73, Number 230 (Friday, November 28, 2008)]
[Notices]
[Page 72495]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-28208]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Cancer Institute Special Emphasis Panel, February 11, 2009, 8 a.m. to
February 13, 2009, 5 p.m., Hilton Washington/Rockville, 1750 Rockville
Pike, Rockville, MD 20852 which was published in the Federal Register
on October 15, 2008, 73 FR 61143.
This notice is amended to change the date & time from February 11,
2009, 8 a.m. to February 13, 2009, 5 p.m. to February 11, 7 a.m. to
February 12, 2009, 5 p.m. The meeting is closed to the public.
Dated: November 20, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-28208 Filed 11-26-08; 8:45 am]
BILLING CODE 4140-01-P
